Publish date:

Pfizer Fourth-Quarter Results Match Estimates

Drug maker


(PFE) - Get Pfizer Inc. Report

Wednesday met Wall Street's fourth-quarter earnings estimates and forecast slightly weaker-than-expected earnings for 2001.

The company best known for the anti-impotence pill


reported sturdy earnings of 27 cents per share, or $1.78 billion, matching the consensus estimate of 26 Wall Street analysts polled by

First Call/Thomson Financial

. In the same quarter a year ago, the company earned $1.47 billion, or 23 cents a share.

New York-based Pfizer said its results were lifted by sales of its anti-cholesterol drug

TheStreet Recommends


and arthritis drug



For 2001, the company expects to earn $1.27 a share, 3 cents shy of the consensus estimate.

Pfizer's stock was recently trading down slightly at $42.06 in pre-market


trading, having closed at $42.88 Tuesday on the

New York Stock Exchange